# ClinicalTrials.gov record NCT03651765

> PeptideScanner retained ClinicalTrials.gov record NCT03651765 at 2026-07-30T18:27:14.161Z. Its registry update date was 2025-05-31, and PeptideScanner's reviewed identity mapping was setmelanotide.

- Evidence object: `story:clinicaltrials-gov-nct03651765-setmelanotide:v1`
- Evidence domain: Clinical trials
- Date in source: 2025-05-31
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-09
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct03651765-setmelanotide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct03651765-setmelanotide-v1.json
- Content SHA-256: `a081d04fb87b3b1f3dbef4ffba01eeec1ed979cae7ca9cc38e7861695f680a20`

## Claims and source pins

### Headline

ClinicalTrials.gov record NCT03651765 ([`ctg-observation-nct03651765-2025-05-31-de63add01879`](#source-ctg-observation-nct03651765-2025-05-31-de63add01879))

### Summary

PeptideScanner retained ClinicalTrials.gov record NCT03651765 at 2026-07-30T18:27:14.161Z. Its registry update date was 2025-05-31, and PeptideScanner's reviewed identity mapping was setmelanotide. ([`ctg-observation-nct03651765-2025-05-31-de63add01879`](#source-ctg-observation-nct03651765-2025-05-31-de63add01879))

### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT03651765 at 2026-07-30T18:27:14.161Z. Its registry update date was 2025-05-31, and PeptideScanner's reviewed identity mapping was setmelanotide. ([`ctg-observation-nct03651765-2025-05-31-de63add01879`](#source-ctg-observation-nct03651765-2025-05-31-de63add01879))

### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct03651765-2025-05-31-de63add01879`](#source-ctg-observation-nct03651765-2025-05-31-de63add01879))

## Sources

<a id="source-ctg-observation-nct03651765-2025-05-31-de63add01879"></a>
- **ClinicalTrials.gov record NCT03651765 · retained source version 2025-05-31:de63add01879f55e83df498a9cc110668a1655ca46e495ff9b59ba2721836ecc** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT03651765) (`ctg-observation-nct03651765-2025-05-31-de63add01879`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT03651765." Version 1, published 2026-08-09. https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct03651765-setmelanotide-v1.json SHA-256: a081d04fb87b3b1f3dbef4ffba01eeec1ed979cae7ca9cc38e7861695f680a20.